TORC resTORbio Inc.

+0.54  (+5%)
Previous Close 9.85
Open 10.01
Price To Book 2.64
Market Cap 371,372,658
Shares 35,743,278
Volume 208,845
Short Ratio
Av. Daily Volume 132,581

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 top-line data due mid-2020.
RTB101 and Everolimus
Respiratory Tract Infections
Phase 2 data due 2020.
Parkinson's disease

Latest News

  1. resTORbio, Inc.'s Shares March Higher, Can It Continue?
  2. Introducing resTORbio (NASDAQ:TORC), The Stock That Dropped 20% In The Last Year
  3. resTORbio Presents Additional Phase 2b Data at the American Thoracic Society International Conference for RTB101 as a Potential Immunotherapy to Reduce the Incidence of Respiratory Tract Infections in Patients 65 Years of Age and Older with Asthma
  4. resTORbio Reports First Quarter 2019 Financial Results and Corporate Update
  5. resTORbio Appoints Lloyd Klickstein, M.D., Ph.D., as Chief Scientific Officer
  6. resTORbio to Present RTB101 Phase 2b Clinical Trial Data at American Thoracic Society 2019 International Conference
  7. resTORbio Announces Initiation of Phase 3 Clinical Program of RTB101 in Clinically Symptomatic Respiratory Illness
  8. resTORbio to Participate at Upcoming Investor Conferences in May
  9. featured expert Kevin Matras highlights: Walker & Dunlop, Herc, ICICI Bank, HDFC Bank and resTORbio
  10. Buy These 5 Stocks as New Analysts Initiate Coverage
  11. resTORbio Announces Initiation of Phase 1b/2a Trial of RTB101 in Parkinson’s Disease
  12. resTORbio, Inc. Announces Closing Public Offering of Common Stock
  13. resTORbio, Inc. Announces Pricing of Public Offering of Common Stock
  14. resTORbio, Inc. Announces Proposed Public Offering of Common Stock
  15. resTORbio Reports Fourth Quarter and Full Year 2018 Financial Results
  16. resTORbio Announces Positive End-of-Phase 2 Meeting with FDA and Planned Initiation of Global Phase 3 Program for RTB101
  17. resTORbio to Present at 8th Annual SVB Leerink Global Healthcare Conference
  18. resTORbio Appoints Erkan Baloglu, Ph.D., M.B.A., as Vice President of Drug Discovery and Medicinal Chemistry
  19. resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition and Neurodegenerative Disease
  20. resTORbio Appoints William Marshall, M.D., as Vice President of Medical Sciences